RATIONALE: Pseudomonas aeruginosa is the most commonly isolated gram-negative bacterium after lung transplantation and has been shown to up-regulate glutamic acid-leucine-arginine-positive (ELR(+)) CXC chemokines associated with bronchiolitis obliterans syndrome (BOS), but the effect of pseudomonas on BOS and death has not been well defined. OBJECTIVES: To determine if the influence of pseudomonas isolation and ELR(+) CXC chemokines on the subsequent development of BOS and the occurrence of death is time dependent. METHODS: A three-state model was developed to assess the likelihood of transitioning from lung transplant (state 1) to BOS (state 2), from transplant (state 1) to death (state 3), and from BOS (state 2) to death (state 3). This Cox semi-Markovian approach determines state survival rates and cause-specific hazards for movement from one state to another. MEASUREMENTS AND MAIN RESULTS: The likelihood of transition from transplant to BOS was increased by acute rejection, CXCL5, and the interaction between pseudomonas and CXCL1. The pseudomonas effect in this transition was due to infection rather than colonization. Movement from transplant to death was facilitated by pseudomonas infection and single lung transplant. Transition from BOS to death was affected by the length of time in state 1 and by the interactions between any pseudomonas isolation and CXCL5 and aspergillus, either independently or in combination. CONCLUSIONS: Our model demonstrates that common post-transplantation events drive movement from one post-transplantation state to another and influence outcomes differently depending upon when after transplantation they occur. Pseudomonas and the ELR(+) CXC chemokines may interact to negatively influence lung transplant outcomes.
RATIONALE: Pseudomonas aeruginosa is the most commonly isolated gram-negative bacterium after lung transplantation and has been shown to up-regulate glutamic acid-leucine-arginine-positive (ELR(+)) CXC chemokines associated with bronchiolitis obliterans syndrome (BOS), but the effect of pseudomonas on BOS and death has not been well defined. OBJECTIVES: To determine if the influence of pseudomonas isolation and ELR(+) CXC chemokines on the subsequent development of BOS and the occurrence of death is time dependent. METHODS: A three-state model was developed to assess the likelihood of transitioning from lung transplant (state 1) to BOS (state 2), from transplant (state 1) to death (state 3), and from BOS (state 2) to death (state 3). This Cox semi-Markovian approach determines state survival rates and cause-specific hazards for movement from one state to another. MEASUREMENTS AND MAIN RESULTS: The likelihood of transition from transplant to BOS was increased by acute rejection, CXCL5, and the interaction between pseudomonas and CXCL1. The pseudomonas effect in this transition was due to infection rather than colonization. Movement from transplant to death was facilitated by pseudomonasinfection and single lung transplant. Transition from BOS to death was affected by the length of time in state 1 and by the interactions between any pseudomonas isolation and CXCL5 and aspergillus, either independently or in combination. CONCLUSIONS: Our model demonstrates that common post-transplantation events drive movement from one post-transplantation state to another and influence outcomes differently depending upon when after transplantation they occur. Pseudomonas and the ELR(+) CXC chemokines may interact to negatively influence lung transplant outcomes.
Authors: Marc Estenne; Janet R Maurer; Annette Boehler; James J Egan; Adaani Frost; Marshall Hertz; George B Mallory; Gregory I Snell; Samuel Yousem Journal: J Heart Lung Transplant Date: 2002-03 Impact factor: 10.247
Authors: R Vos; B M Vanaudenaerde; S E Verleden; S I De Vleeschauwer; A Willems-Widyastuti; D E Van Raemdonck; A Schoonis; T S Nawrot; L J Dupont; G M Verleden Journal: Eur Respir J Date: 2010-06-18 Impact factor: 16.671
Authors: S S Weigt; A Derhovanessian; E Liao; S Hu; A L Gregson; B M Kubak; R Saggar; R Saggar; V Plachevskiy; M C Fishbein; J P Lynch; A Ardehali; D J Ross; H-J Wang; R M Elashoff; J A Belperio Journal: Am J Transplant Date: 2011-12-07 Impact factor: 8.086
Authors: Shawn D Aaron; Katherine L Vandemheen; Karam Ramotar; Tracy Giesbrecht-Lewis; Elizabeth Tullis; Andreas Freitag; Nigel Paterson; Mary Jackson; M Diane Lougheed; Christopher Dowson; Vijay Kumar; Wendy Ferris; Francis Chan; Steve Doucette; Dean Fergusson Journal: JAMA Date: 2010-11-17 Impact factor: 56.272
Authors: Aric L Gregson; Aki Hoji; Vyacheslav Palchevskiy; Scott Hu; S Samuel Weigt; Eileen Liao; Ariss Derhovanessian; Rajeev Saggar; Sophie Song; Robert Elashoff; Otto O Yang; John A Belperio Journal: PLoS One Date: 2010-06-29 Impact factor: 3.240
Authors: Richard D Sue; John A Belperio; Marie D Burdick; Lynne A Murray; Ying Ying Xue; Maria C Dy; Jeffery J Kwon; Michael P Keane; Robert M Strieter Journal: J Immunol Date: 2004-03-15 Impact factor: 5.422
Authors: Michael P Keane; Seamas C Donnelly; John A Belperio; Richard B Goodman; Maria Dy; Marie D Burdick; Michael C Fishbein; Robert M Strieter Journal: J Immunol Date: 2002-12-01 Impact factor: 5.422
Authors: S S Weigt; R M Elashoff; M P Keane; R M Strieter; B N Gomperts; Y Y Xue; A Ardehali; A L Gregson; B Kubak; M C Fishbein; R Saggar; D J Ross; J P Lynch; D A Zisman; J A Belperio Journal: Am J Transplant Date: 2008-07 Impact factor: 8.086
Authors: Aric L Gregson; Aki Hoji; Patil Injean; Steven T Poynter; Claudia Briones; Vyacheslav Palchevskiy; S Sam Weigt; Michael Y Shino; Ariss Derhovanessian; David Sayah; Rajan Saggar; David Ross; Abbas Ardehali; Joseph P Lynch; John A Belperio Journal: Am J Respir Crit Care Med Date: 2015-12-15 Impact factor: 21.405
Authors: A L Gregson; X Wang; P Injean; S S Weigt; M Shino; D Sayah; A DerHovanessian; J P Lynch; D J Ross; R Saggar; A Ardehali; G Li; R Elashoff; J A Belperio Journal: Am J Transplant Date: 2015-02-12 Impact factor: 8.086
Authors: S Samuel Weigt; Xiaoyan Wang; Vyacheslav Palchevskiy; Naman Patel; Ariss Derhovanessian; Michael Y Shino; David M Sayah; Joseph P Lynch; Rajan Saggar; David J Ross; Bernie M Kubak; Abbas Ardehali; Scott Palmer; Shahid Husain; John A Belperio Journal: Transplantation Date: 2018-06 Impact factor: 4.939
Authors: Paul R Allyn; Erin L Duffy; Romney M Humphries; Patil Injean; S Samuel Weigt; Rajan Saggar; Michael Y Shino; Joseph P Lynch; Abbas Ardehali; Bernard Kubak; Chi-Hong Tseng; John A Belperio; David J Ross; Aric L Gregson Journal: Transplantation Date: 2016-11 Impact factor: 4.939
Authors: Hrishikesh S Kulkarni; Kevin Tsui; Suraj Sunder; Alex Ganninger; Laneshia K Tague; Chad A Witt; Derek E Byers; Elbert P Trulock; Ruben Nava; Varun Puri; Daniel Kreisel; Thalachallour Mohanakumar; Andrew E Gelman; Ramsey R Hachem Journal: Am J Transplant Date: 2019-12-24 Impact factor: 8.086